EUROFINS SCIENTIFIC (ERF.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ERF - FR0014000MR3 - Common Stock
72 EUR
-1.12 (-1.53%)
We assign a fundamental rating of 5 out of 10 to ERF. ERF was compared to 22 industry peers in the Life Sciences Tools & Services industry. ERF has only an average score on both its financial health and profitability. ERF has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ERF was profitable.
- ERF had a positive operating cash flow in the past year.
- ERF had positive earnings in each of the past 5 years.
- ERF had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- ERF's Return On Assets of 3.54% is in line compared to the rest of the industry. ERF outperforms 45.45% of its industry peers.
- Looking at the Return On Equity, with a value of 8.09%, ERF is in line with its industry, outperforming 59.09% of the companies in the same industry.
- With a decent Return On Invested Capital value of 9.79%, ERF is doing good in the industry, outperforming 72.73% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ERF is in line with the industry average of 9.34%.
- The 3 year average ROIC (8.70%) for ERF is below the current ROIC(9.79%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
- ERF has a Profit Margin of 5.44%. This is in the lower half of the industry: ERF underperforms 63.64% of its industry peers.
- ERF's Profit Margin has improved in the last couple of years.
- With a Operating Margin value of 15.59%, ERF perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of ERF has grown nicely.
- ERF's Gross Margin of 23.29% is on the low side compared to the rest of the industry. ERF is outperformed by 81.82% of its industry peers.
- In the last couple of years the Gross Margin of ERF has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ERF is still creating some value.
- ERF has less shares outstanding than it did 1 year ago.
- ERF has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for ERF has been reduced compared to a year ago.
2.2 Solvency
- ERF has an Altman-Z score of 2.90. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
- ERF has a Altman-Z score (2.90) which is comparable to the rest of the industry.
- The Debt to FCF ratio of ERF is 5.24, which is a neutral value as it means it would take ERF, 5.24 years of fcf income to pay off all of its debts.
- ERF has a Debt to FCF ratio (5.24) which is in line with its industry peers.
- A Debt/Equity ratio of 0.77 indicates that ERF is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.77, ERF is doing worse than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.24 | ||
| Altman-Z | 2.9 |
ROIC/WACC1.16
WACC8.47%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that ERF should not have too much problems paying its short term obligations.
- ERF has a Current ratio (1.26) which is comparable to the rest of the industry.
- ERF has a Quick Ratio of 1.19. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
- ERF has a Quick ratio of 1.19. This is amongst the best in the industry. ERF outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
- ERF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.50%, which is quite good.
- Measured over the past years, ERF shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
- ERF shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
- ERF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.78% yearly.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
- ERF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.68% yearly.
- ERF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.25% yearly.
EPS Next Y14.67%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPS Next 5Y15.68%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 20.00, ERF is valued on the expensive side.
- 77.27% of the companies in the same industry are more expensive than ERF, based on the Price/Earnings ratio.
- ERF's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.33.
- ERF is valuated rather expensively with a Price/Forward Earnings ratio of 18.08.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ERF indicates a somewhat cheap valuation: ERF is cheaper than 77.27% of the companies listed in the same industry.
- ERF's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20 | ||
| Fwd PE | 18.08 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ERF indicates a rather cheap valuation: ERF is cheaper than 81.82% of the companies listed in the same industry.
- ERF's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ERF is cheaper than 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.72 | ||
| EV/EBITDA | 9.82 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- ERF has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as ERF's earnings are expected to grow with 13.98% in the coming years.
PEG (NY)1.36
PEG (5Y)1.09
EPS Next 2Y13.53%
EPS Next 3Y13.98%
5. Dividend
5.1 Amount
- ERF has a yearly dividend return of 0.87%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.54, ERF pays a better dividend. On top of this ERF pays more dividend than 86.36% of the companies listed in the same industry.
- With a Dividend Yield of 0.87, ERF pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
- On average, the dividend of ERF grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- ERF pays out 54.88% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of ERF is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.88%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPA:ERF (1/14/2026, 7:00:00 PM)
72
-1.12 (-1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-21 2025-10-21
Earnings (Next)01-29 2026-01-29/amc
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap13.12B
Revenue(TTM)6.89B
Net Income(TTM)375.00M
Analysts68.42
Price Target65.73 (-8.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.2%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20 | ||
| Fwd PE | 18.08 | ||
| P/S | 1.9 | ||
| P/FCF | 16.72 | ||
| P/OCF | 9.97 | ||
| P/B | 2.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.82 |
EPS(TTM)3.6
EY5%
EPS(NY)3.98
Fwd EY5.53%
FCF(TTM)4.31
FCFY5.98%
OCF(TTM)7.22
OCFY10.03%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.36
PEG (5Y)1.09
Graham Number45.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.65% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.11% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.38% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.24 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.98% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.99 | ||
| Cash Conversion | 77.4% | ||
| Profit Quality | 209.23% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.9 |
F-Score7
WACC8.47%
ROIC/WACC1.16
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.67%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPS Next 5Y15.68%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%
EBIT growth 1Y14.06%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year83.84%
EBIT Next 3Y29.91%
EBIT Next 5Y21.82%
FCF growth 1Y113.26%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.36%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%
EUROFINS SCIENTIFIC / ERF.PA FAQ
What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.
What is the valuation status for ERF stock?
ChartMill assigns a valuation rating of 6 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for EUROFINS SCIENTIFIC?
EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for EUROFINS SCIENTIFIC?
The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 14.67% in the next year.
Can you provide the dividend sustainability for ERF stock?
The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 4 / 10 and the dividend payout ratio is 54.88%.